I asked this question when I contacted management. There may be a prospective study required once the biomarkers are recognized, however they may compare the data from the US trial against the Indian trial as they most likely already have trained the algorithms from the Indian study. This should show us the accuracy IMO... and if highly accurate there's no reason why it cannot be pushed through the healthcare system at a rapid pace via emergency clearance as the product is required now not in several months time although the dreaded virus will still be lingering I'm sure for years to come so this will still be a viable tool in the future...
What I like about this company is that we have a huge PRE-COVID Library of cough signatures to compare against. If we can show that we can accurately identify COVID between other cough sounds with high accuracy and prove that there is a distinguishable cough it's game on!!
All just my opinion only
Cheers
Red bar
- Forums
- ASX - By Stock
- RAP
- COVID-19 Instant Screening test
COVID-19 Instant Screening test, page-446
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 576 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)